A detailed history of Rothschild Investment LLC transactions in Geron Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 225 shares of GERN stock, worth $1,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Holding current value
$1,066
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$3.1 - $5.09 $697 - $1,145
225 New
225 $954,000
Q1 2024

Jul 31, 2024

SELL
$1.75 - $3.44 $323 - $636
-185 Reduced 82.22%
40 $132,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.79B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.